Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma

Clinical trial NCT04512534 · RECRUITING

Trial details

NCT number: NCT04512534
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma

Start date: 2020-11-13
Primary completion: 2026-12-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.